/People

Ian Peikon

InvestorFounder

Venture Partner at Lux Capital · Co-Founder and Co-Chief Executive Officer at Cajal Neuroscience

New York, New York

Writes $1M – $50M checks · typically $10M

FoundedCajal Neuroscience

Find your path to Ian

280 people in our graph can introduce you to Ian.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Adam Goulburn to introduce you to Ian

You →Adam · together at Kallyope (2015) →Ian

Ask Jamie Chen to introduce you to Ian

You →Jamie · 2 people · together at Kallyope →Ian

Ask Sam Okafor to introduce you to Ian

You →Sam · 9 people · together at Lux Capital →Ian

Sign up to find every way you can get introduced to Ian

  • Your email: the people you already email who know Ian
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Ian
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.

Co-Founder and Co-Chief Executive Officer at Cajal Neuroscience

Intro paths

→

In turn, Ian can intro founders to Cajal Neuroscience's investors below.

Co-founders at Cajal Neuroscience

AD
Andrew DervanCo-Founder and Co-Chief Executive Officer
RHRob Hershberg
Rob HershbergCo-Founder and Executive Chairman

Experience

  1. Cajal TherapeuticsCo-Founder & Co-Chief Executive Officercurrent2020 — present
  2. Lux CapitalVenture Partnercurrent2019 — presentGreater New York City Area
  3. Cold Spring Harbor Laboratory Library and ArchivesAdvisory Board Membercurrent2024 — presentCold Spring Harbor, New York, United States
  4. PlexiumBoard Member2022 — 2025
  5. VNV BioCo-Founder & SAB Member2018 — 2022Greater New York City Area
  6. KallyopeCo-Founder & Director, Platform Biology & Technology2015 — 2019

Skills & more

Molecular Biology19Neuroscience12Biotechnology2Start-ups1Biomedical Engineering10Electrophysiology8Fluorescence Microscopy19Confocal Microscopy16Genetics8Matlab8Cell Biology10C++4
+8 moreComputational BiologyBioinformaticsSynthetic BiologyProtein PurificationWestern BlottingPCREmulsion PCRCell Culture

From Ian's professional profile.

Investments

Per curated public sources.

Colleagues at Lux Capital

Network7

Investors connected to Ian in public investor directories — a warm-intro map.

Frequently asked questions

Who is Ian Peikon?
Ian Peikon is co-founder and co-chief executive officer of Cajal Therapeutics. He brings experience in team leadership and scientific research, with background in molecular biology, neuroscience, and biomedical engineering.
Where does Ian Peikon work?
Ian Peikon is Co-Founder and Co-Chief Executive Officer of Cajal Neuroscience and Venture Partner at Lux Capital.
What check size does Ian Peikon write?
Ian Peikon typically writes checks of $1M – $50M.
What companies did Ian Peikon found?
Ian Peikon founded Cajal Neuroscience.
What companies has Ian Peikon invested in?
Investments tracked here include Cajal Neuroscience.
Where did Ian Peikon go to school?
Ian Peikon studied at Cold Spring Harbor Laboratory (PhD, Biological Sciences); Duke University (BSE, Biomedical Engineering).

Founder mafias

Same school

Shared employers